The present study aims to explore whether Schisandra chinensis
Baill, a Chinese, medicinal herb can alleviates
high-fat-diet-inducing non-alcoholic steatohepatitis in rats.
Materials and Methods:
In the study, 24, male Wister rats with body weight between 180-220g, were included. The rats were randomly divided
into four groups: model group, normal control group, rosiglitazone group, and Schisandra chinensis
Baill group. The treatment lasted for 56, days.
The high-fat diet used in the present study includes 25% lard, 2%, cholesterol 0.5%, sodium cholate, and 25%, Tween-80. The hepatic levels of
superoxide dismutase (SOD), and malondialdehyde (MDA); the serum levels of total cholesterol (TC), and low-density lipoprotein cholesterol
(LDLC), were detected.
We found that the hepatic levels of SOD were significantly lower, and the serum levels of TC, LDLC as well as, the hepatic levels of
MDA in model group were significantly higher than those of normal control group; rosiglitazone group and Schisandra chinensis
(P<0.05), indicates that non-alcoholic steatohepatitis rats were successfully induced by high-fat diet. Schisandra chinensis
Baill group presented a
significant lower serum levels of LDLC, than rosiglitazone group (P<0.05); and the hepatic levels of SOD in Schisandra chinensis
were significantly lower than rosiglitazone group (P<0.05). However, no significant difference existed between Schisandra chinensis
and rosiglitazone group on the hepatic levels of MDA and the serum levels of TC (P>0.05).
It is then concluded that Schisandra chinensis
Baill can significantly alleviate the non-alcoholic steatohepatitis of the rats induced by
high-fat diet, and it may be used as a complementary therapy for rosiglitazone.